TNPSC Thervupettagam

Covovax as booster dose

January 24 , 2023 59 days 136 0
  • The Drug Controller General of India (DCGI) has approved the use of Serum Institute of India’s (SII) Covovax as a heterologous booster dose.
  • This can be used for those who have previously taken two doses of Covaxin or Covishield.
  • A heterologous booster is when the third dose is different from the earlier doses.
  • Covovax is manufactured through technology transfer from Novavax.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *